Recent Advances in Long-Acting Drug Delivery and Formulations
The Special Issue titled "Recent Advances in Long-Acting Drug Delivery and Formulations" encompasses versatile and innovative research domains of oral, ocular, brain, and topical delivery systems and chemical approaches (e.g., prodrugs), highlighting the progress made in identifying excipi...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_128848 | ||
| 005 | 20231130 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20231130s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-9438-5 | ||
| 020 | |a 9783036594392 | ||
| 020 | |a 9783036594385 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-9438-5 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a KNDP |2 bicssc | |
| 100 | 1 | |a Abdelkader, Hamdy |4 edt | |
| 700 | 1 | |a Al-Fatease, Adel |4 edt | |
| 700 | 1 | |a Abdelkader, Hamdy |4 oth | |
| 700 | 1 | |a Al-Fatease, Adel |4 oth | |
| 245 | 1 | 0 | |a Recent Advances in Long-Acting Drug Delivery and Formulations |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (234 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a The Special Issue titled "Recent Advances in Long-Acting Drug Delivery and Formulations" encompasses versatile and innovative research domains of oral, ocular, brain, and topical delivery systems and chemical approaches (e.g., prodrugs), highlighting the progress made in identifying excipients (e.g., basic amino acids to ameliorate gastric side effects of non-steroidal anti-inflammatory drugs (NSAIDs)), polymers, and molecular targets to achieve more effective sustained release systems and safer medicine. In this Special Issue, 78 authors have contributed, with eleven original research articles spanning five continents (Asia, Europe, Africa, North America, and Australasia) providing important insights into the pharmaceutical sciences. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Pharmaceutical industries |2 bicssc | |
| 653 | |a drug delivery | ||
| 653 | |a nanotechnology | ||
| 653 | |a alzheimer's disease | ||
| 653 | |a Amyloid-β | ||
| 653 | |a solid lipid nanoparticles | ||
| 653 | |a SHSY5Y cells | ||
| 653 | |a altretamine | ||
| 653 | |a cancer therapy | ||
| 653 | |a sustained delivery | ||
| 653 | |a hydroxyapatite nanoparticles | ||
| 653 | |a chemical precipitation method | ||
| 653 | |a polymeric film | ||
| 653 | |a diabetes mellitus | ||
| 653 | |a skin regeneration | ||
| 653 | |a wound healing | ||
| 653 | |a sodium alginate | ||
| 653 | |a sodium carboxy methyl cellulose | ||
| 653 | |a microwave | ||
| 653 | |a cross-linking | ||
| 653 | |a ketoprofen | ||
| 653 | |a L-arginine | ||
| 653 | |a L-lysine | ||
| 653 | |a tris | ||
| 653 | |a basic amino acids | ||
| 653 | |a writhing | ||
| 653 | |a gastric ulcer | ||
| 653 | |a chitosan | ||
| 653 | |a 1,3,5-benzene tricarboxylic acid | ||
| 653 | |a hydrogels | ||
| 653 | |a rheology | ||
| 653 | |a alginate | ||
| 653 | |a BSA | ||
| 653 | |a Maillard reaction | ||
| 653 | |a age-related-macular degeneration | ||
| 653 | |a drug release | ||
| 653 | |a fenofibrate | ||
| 653 | |a retinal cells | ||
| 653 | |a HIV | ||
| 653 | |a long-acting subcutaneous injection | ||
| 653 | |a raltegravir | ||
| 653 | |a cyclisation-activated prodrugs | ||
| 653 | |a β-blockers | ||
| 653 | |a NSAIDs | ||
| 653 | |a corticosteroids | ||
| 653 | |a ocular delivery | ||
| 653 | |a drug permeability | ||
| 653 | |a QSPR | ||
| 653 | |a MLR | ||
| 653 | |a Alzheimer's disease | ||
| 653 | |a GSK-3β-Wnt/β-catenin | ||
| 653 | |a PERK/CHOP/Bcl-2 | ||
| 653 | |a oxidative stress | ||
| 653 | |a cocoa | ||
| 653 | |a vinpocetine | ||
| 653 | |a diabetes | ||
| 653 | |a salbutamol | ||
| 653 | |a skeletal muscle atrophy | ||
| 653 | |a sarcosine | ||
| 653 | |a metabolomics | ||
| 653 | |a factorial design | ||
| 653 | |a controlled release | ||
| 653 | |a topical delivery | ||
| 653 | |a texture analysis | ||
| 653 | |a bioadhesion | ||
| 653 | |a intermolecular interactions | ||
| 653 | |a hydroxypropyl methylcellulose | ||
| 653 | |a polyvinylpyrrolidone | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/8318 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/128848 |7 0 |z DOAB: description of the publication |